rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0014939,
umls-concept:C0017262,
umls-concept:C0033308,
umls-concept:C0185117,
umls-concept:C0279781,
umls-concept:C0521425,
umls-concept:C0677850,
umls-concept:C1257890,
umls-concept:C1514307,
umls-concept:C1707455,
umls-concept:C1709940,
umls-concept:C2603343,
umls-concept:C2911684
|
pubmed:issue |
9
|
pubmed:dateCreated |
2008-3-19
|
pubmed:abstractText |
To centrally assess estrogen receptor (ER) and progesterone receptor (PgR) levels by immunohistochemistry and investigate their predictive value for benefit of chemo-endocrine compared with endocrine adjuvant therapy alone in two randomized clinical trials for node-negative breast cancer.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:BrayeStephenS,
pubmed-author:BrownRobert WRW,
pubmed-author:Castiglione-GertschMonicaM,
pubmed-author:CoatesAlan SAS,
pubmed-author:GelberRichard DRD,
pubmed-author:GoldhirschAronA,
pubmed-author:GolouhRastkoR,
pubmed-author:GrigolatoPiergiovanniP,
pubmed-author:GustersonBarry ABA,
pubmed-author:KovácsAnikóA,
pubmed-author:MaioranoEugenioE,
pubmed-author:MastropasquaMauro GMG,
pubmed-author:OhlschlegelChristianC,
pubmed-author:PerinTizianaT,
pubmed-author:PillayKomalaK,
pubmed-author:PriceKaren NKN,
pubmed-author:ReganMeredith MMM,
pubmed-author:RuscaTizianaT,
pubmed-author:VialeGiuseppeG
|
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1404-10
|
pubmed:dateRevised |
2009-5-21
|
pubmed:meshHeading |
pubmed-meshheading:18349391-Adult,
pubmed-meshheading:18349391-Aged,
pubmed-meshheading:18349391-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18349391-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18349391-Breast Neoplasms,
pubmed-meshheading:18349391-Chemotherapy, Adjuvant,
pubmed-meshheading:18349391-Cyclophosphamide,
pubmed-meshheading:18349391-Disease-Free Survival,
pubmed-meshheading:18349391-Female,
pubmed-meshheading:18349391-Fluorouracil,
pubmed-meshheading:18349391-Goserelin,
pubmed-meshheading:18349391-Humans,
pubmed-meshheading:18349391-Immunohistochemistry,
pubmed-meshheading:18349391-Menopause,
pubmed-meshheading:18349391-Methotrexate,
pubmed-meshheading:18349391-Middle Aged,
pubmed-meshheading:18349391-Neoplasms, Hormone-Dependent,
pubmed-meshheading:18349391-Predictive Value of Tests,
pubmed-meshheading:18349391-Receptors, Estrogen,
pubmed-meshheading:18349391-Receptors, Progesterone,
pubmed-meshheading:18349391-Tamoxifen,
pubmed-meshheading:18349391-Treatment Outcome,
pubmed-meshheading:18349391-Tumor Markers, Biological
|
pubmed:year |
2008
|
pubmed:articleTitle |
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
|
pubmed:affiliation |
Division of Pathology and Laboratory Medicine, European Institute of Oncology, University of Milan, Milan, Italy. giuseppe.viale@ieo.it
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|